Trastuzumab. Molecular model of the drug trastuzumab. This drug, sold under the brand name Herceptin, is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain breast cancers. The image shows the molecule with antibody light and heavy chains (green and violet) and the receptor protein-tyrosine kinase (red).